Propiedad y actividad de insiders de AEON Biopharma, Inc. (AEON): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.26 |
| Capitalización | $11M |
| Bolsa | AMEX |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-19 | LYNCH TIMOTHY P | P-Purchase | 1,150,000 | $243K |
| 2026-08-19 | LYNCH TIMOTHY P | |||
| 2026-08-19 | LYNCH TIMOTHY P | 1,000,000 | $100 | |
| 2026-07-15 | LYNCH TIMOTHY P | 3,000,000 | $966K | |
| 2026-07-15 | LYNCH TIMOTHY P | 3,000,000 | $1.1M | |
| 2026-06-17 | Thunen Shelley B | A-Award | 222,684 | |
| 2026-06-17 | PALMISANO ROBERT J | A-Award | 222,684 | |
| 2026-06-17 | Forth Marc | A-Award | 222,684 | |
| 2026-06-17 | FISCHER JOST | A-Award | 222,684 | |
| 2026-06-17 | Carter Eric G | A-Award | 222,684 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $6.3M | $20.2M | $5.1M | $9.7M | $5.2M | $13000 | $3.0M |
| Inversiones a Corto | $105.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $267000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $112.1M | $20.4M | $5.2M | $9.8M | $6.2M | $1.6M | $3.4M |
| Inmovilizado Material | 0 | 0 | $922000 | $906000 | $594000 | $1.5M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $114.4M | $21.2M | $6.4M | $10.8M | $6.8M | $3.1M | $5.6M |
| Cuentas por Pagar | $1.0M | $2.0M | $1.2M | $7.8M | $3.4M | $5.9M | $942000 |
| Deuda a Corto | $14.8M | 0 | $15.6M | $70.9M | 0 | 0 | 0 |
| Pasivos Corrientes | $17.5M | $4.2M | $20.8M | $82.6M | $13.0M | $14.1M | $6.9M |
| Deuda a Largo | $15.2M | $72.2M | $70.8M | $60.4M | 0 | $11.7M | $34.6M |
| Pasivos Totales | $180.2M | $224.4M | $230.3M | $281.2M | $159.9M | $31.7M | $60.6M |
| Reservas | -$333.7M | -$366.6M | -$422.3M | -$474.8M | -$473.6M | -$431.6M | -$470.8M |
| Patrimonio Neto | -$67.2M | -$208.3M | -$234.9M | -$287.5M | -$153.0M | -$28.6M | -$55.0M |
| Deuda Total | $30.0M | $72.2M | $86.9M | $131.5M | $278000 | $13.0M | $35.7M |
| Deuda Neta | -$81.8M | $52.0M | $81.8M | $121.8M | -$4.9M | $12.9M | $32.7M |
| Capital Circulante | $94.7M | $16.2M | -$15.7M | -$72.7M | -$6.8M | -$12.6M | -$3.5M |
Salud financiera
| Deuda / Patrimonio | -0.18 |
| Ratio corriente | 0.54 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -126.80 |
Rentabilidad
| Rentabilidad sobre capital | 204.18% |
| Rentabilidad sobre capital invertido | 1699.74% |
| Rentabilidad sobre activos | -924.25% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ABP · APM · BOLT · CING · CLNN · CLRB · LYRA
Explorar sector: Healthcare · Biotechnology
Más secciones de AEON: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones